Breaking News

CPhI Awards 2021 open for entries

Held as part of CPhI Worldwide, which takes place 9-11 November 2021, the awards span the entire pharmaceutical supply ...

Eisai and Merck combination cancer therapy approved by FDA

The approval for this population is based on results from a Phase III Study 309/KEYNOTE-775 trial

Catalent plans $100 million expansion of Italian facility

The initial phase of the expansion will see the installation of two 2,000 L single-use bioreactors within purpose-built ...

What does a pharmaceutical integrated services programme entail?

Here Kevin Duffield, Head of Client Services North America/United Kingdom discusses key attributes to look for in an ...

Minaris to manufacture Bluebird Bio therapy for CALD

Early Cerebral Adrenoleukodystrophy is a life-threatening progressive neurodegenerative disease

Nanopharm and Leyden Labs to develop nasal sprays for virus protection

Leyden Labs’ platform targets commonalities of viral families to develop candidates that protect against many strains ...

Opportunities to scale AAV viral vector production for gene therapies

Gene therapies hold tremendous potential as a treatment modality for inherited human diseases. This emerging ...

Aptamer Group and WuXi AppTec collaborate on Optimer therapeutics

As part of the agreement, Aptamer will develop Optimers to specific disease biomarkers and supply them to WuXi for ...

Vetter completes integration of Austrian manufacturing site

The site currently offers 100,000 sqft of offices, laboratory space, areas for material preparation

Oncolytic viruses: the key to advancing novel therapies to market

As researchers continue to uncover and understand the enormous complexities of cancer, emerging technology and novel ...

Big names confirmed to speak at Manufacturing Chemist Live

NASA and AstraZeneca have joined the extensive list of speakers for the combined virtual and in-person event

Lab standardisation: working smarter to improve patient outcomes

We’re living in a pivotal time for healthcare, reports Benjamin Lilienfeld, LifeCycle Leader at Roche Diagnostics ...

Calliditas and STADA partner to commercialise IgAN therapy

The drug candidate will be commercialised in Switzerland and the UK

Merck receives FDA approval for Vaxneuvance vaccine

The 15-valent pneumococcal vaccine using Ligand’s CRM197 vaccine carrier protein